Taiko Pharmaceutical Company., Limited operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Taiko Pharmaceutical Company., Limited with three other
pharmaceutical manufacturers in Asia:
Ttk Healthcare Limited
sales of 5.19 billion Indian Rupees [US$79.28 million]
of which 53%
Merck Tbk PT
(1.03 trillion Indonesian Rupiahs [US$77.61 million]
of which 49%
was Consumer Health Care), and
Samil Pharmaceutical Co., Ltd.
based in South Korea
(96.76 billion Korean Won [US$86.60 million]
Taiko Pharmaceutical Company., Limited reported sales of ¥8.33 billion (US$74.95 million)
March of 2016.
decrease of 7.3%
versus 2015, when the company's sales were ¥8.98 billion.
Contributing to the drop in overall sales was the 30.7% decline
in Infection Control, from ¥3.20 billion to ¥2.22 billion.
However, these declines were partially offset by the increase in sales of
Medicine Goods (up 5.7% to ¥6.08 billion)
Other (up 15.6% to ¥23.78 million)